These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. New prospects for immunotherapy at diagnosis of type 1 diabetes. Pozzilli P; Leslie RD Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079 [TBL] [Abstract][Full Text] [Related]
23. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897 [TBL] [Abstract][Full Text] [Related]
25. Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass. Waldron-Lynch F; von Herrath M; Herold KC Novartis Found Symp; 2008; 292():146-55; discussion 155-8, 202-3. PubMed ID: 19203097 [TBL] [Abstract][Full Text] [Related]
26. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250 [TBL] [Abstract][Full Text] [Related]
27. Rehabilitation of adaptive immunity and regeneration of beta cells. Pasquali L; Fan Y; Trucco M; Ringquist S Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140 [TBL] [Abstract][Full Text] [Related]
28. Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Koulmanda M; Budo E; Bonner-Weir S; Qipo A; Putheti P; Degauque N; Shi H; Fan Z; Flier JS; Auchincloss H; Zheng XX; Strom TB Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13074-9. PubMed ID: 17670937 [TBL] [Abstract][Full Text] [Related]
29. Islet beta-cell death - fuel to sustain autoimmunity? Filippi CM; von Herrath MG Immunity; 2007 Aug; 27(2):183-5. PubMed ID: 17723211 [TBL] [Abstract][Full Text] [Related]
30. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation. Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702 [TBL] [Abstract][Full Text] [Related]
31. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844 [TBL] [Abstract][Full Text] [Related]
32. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846 [TBL] [Abstract][Full Text] [Related]
33. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. Yang Z; Chen M; Carter JD; Nunemaker CS; Garmey JC; Kimble SD; Nadler JL Biochem Biophys Res Commun; 2006 Jun; 344(3):1017-22. PubMed ID: 16643856 [TBL] [Abstract][Full Text] [Related]
34. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936 [TBL] [Abstract][Full Text] [Related]
35. Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes. Astorri E; Guglielmi C; Bombardieri M; Alessandri C; Buzzetti R; Maggi D; Valesini G; Pitzalis C; Pozzilli P Horm Metab Res; 2010 Dec; 42(13):955-60. PubMed ID: 20972946 [TBL] [Abstract][Full Text] [Related]
37. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate. Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978 [TBL] [Abstract][Full Text] [Related]
38. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]